Stock Screener App

Frei -

Installieren

2.19

2.82% 0.06

after-market

Handel nachbörslich: 2.23 0.04 +1.83%

Century Therapeutics Inc (IPSC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	109.16	4.173	0.791
Operating Expenses	4.21% 36.12	34.66	34.99	41.46	35.58
Benefits Costs and Expenses	47.15% 34.43	65.14	-	38.47	32.02
Costs And Expenses	47.15% 34.43	65.14	-	38.47	32.02
Operating Income/Loss	4.21% -36.12	-34.66	74.18	-37.28	-34.79
Nonoperating Income/Loss	19.83% 1.702	2.123	2.384	2.987	3.555
Income/Loss From Continuing Operations Before Tax	5.78% -34.42	-32.54	76.56	-34.30	-31.23
Income/Loss From Continuing Operations After Tax	5.78% -34.42	-32.54	76.56	-36.07	-31.23
Net Income/Loss	5.78% -34.42	-32.54	76.56	-36.07	-31.23
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.26% 86.46	86.24	86.02	2.2547	84.70
Diluted Average Shares	0.26% 86.46	86.24	86.10	2.2547	84.70
Basic Earnings Per Share	5.26% -0.40	-0.38	0.89	-0.43	-0.37
Diluted Earnings Per Share	5.26% -0.40	-0.38	0.89	-0.43	-0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters